Patents Examined by Carrie R Dorna
-
Patent number: 11911631Abstract: A device having a biocompatible polymer as a body and regularly spaced radiation seeds and regularly spaced magnetic materials disposed of within the body of the biocompatible polymer, or uniformly distributed liquid radiation and magnetic fluid materials within a polymer slab, hollow thick wall polymer shell, or thin wall polymer balloon, as suitable for surgical placement within a resection cavity for treatment of at-risk tissue in the tumor margin with local hyperthermia in combination with radiation and potentially also with chemotherapy and/or immunotherapy that is slowly released from the biocompatible polymer.Type: GrantFiled: March 31, 2017Date of Patent: February 27, 2024Assignees: Thomas Jefferson University, Drexel UniversityInventors: Paul Stauffer, Voichita Bar-ad, Mark Hurwitz, Adam Luginbuhl, Michele Marcolongo, Dario Rodrigues, David Cognetti, Joseph Curry, Katsiaryna Prudnikova
-
Patent number: 11883294Abstract: An anchoring system and related methods are provided for treatment of dilated hearts and of functional valve regurgitation, the system comprising one or more self-expandable or manually expandable anchors and associated devices for fixating a valve splint within the heart. For example, a spade-shaped assembly may be configured to be deployed in a right ventricle of the heart and to stabilize a puncturing instrument to puncture the septum. Various puncturing instruments may also be part of the anchoring system, including one or more of a flexible needle having a multiplicity of slits disposed along the length of the needle, a trocar catheter with a retractable head, and a catheter needle having a blunt introducer to protect nearby tissue within the heart during advancing a guidewire. A cutter catheter and puncture location catheter may also be part of the system and be used during treatment.Type: GrantFiled: May 16, 2022Date of Patent: January 30, 2024Assignee: EDWARDS LIFESCIENCES CORPORATIONInventors: Arie Tylis, Nikolai Gurovich, Eran Goldberg, Boaz Manash, Dan Rottenberg, Hagar Adika, Tal Regev, Dikla Kersh, Danny M. Garmahi, Hernan Altman, Amir Blumenfeld
-
Patent number: 11889272Abstract: An implant configured for secured implantation into a recess formed in a recipient's bone and to removably retain a separate component in a compartment thereof such that the separate component is removable from the implant without removing the implant from the bone.Type: GrantFiled: June 3, 2019Date of Patent: January 30, 2024Assignee: Cochlear LimitedInventors: Wim Bervoets, Patrik Kennes, Bart Carpentier, Marcus Andersson
-
Patent number: 11877829Abstract: A system and method for characterising a narrowing in a fluid filled tube, the system comprising: a probe having a first measurement sensor to take an instantaneous measurement at different locations along the tube; a mechanism to draw the probe through the tube; a position measure to provide location data relating to the location at which a respective instantaneous measurement is taken by the first measurement sensor; a processor to calculate, from the instantaneous measurements, a characteristic of the tube at different locations along the tube.Type: GrantFiled: November 22, 2021Date of Patent: January 23, 2024Assignee: MEDSOLVE LIMITEDInventors: Helen Catherine Stuart Davies, Justin Davies
-
Patent number: 11857806Abstract: Exemplary inventive practice implements Europium Tetrakis Dibenzoylmethide Triethylammonium (EuD4TEA) so as to administer ion beam therapy with extreme precision. An EUD4TEA-inclusive marker (e.g., a solid or gel) is exactingly placed on the skin of a patient in accordance with a predetermined location of cancerous tissue beneath the skin. An ion beam aimed at the EUD4TEA-inclusive marker results in luminescence of at least a portion of the EUD4TEA-inclusive marker, thereby indicating that at least a portion of the ion beam is traveling through the EUD4TEA-inclusive marker and striking the cancer therebelow. According to other modes of exemplary inventive practice, a medical phantom contains a tumor replica that is visibly contrastive inside the medical phantom in terms of luminescence versus non-luminescence. The tumor replica is targeted in ion beam testing to discern optimal geometric and radiative conditions for treating a correspondingly situated patient on the same treatment couch.Type: GrantFiled: July 3, 2019Date of Patent: January 2, 2024Assignee: The United States of America, as represented by the Secretary of the NavyInventors: Ross S. Fontenot, William A. Hollerman, Noel A. Guardala
-
Patent number: 11850441Abstract: Disclosed is an electromagnetic coil system for use during transcranial or transdermal stimulation procedures, in which an electrically conductive coil wraps around a magnetic core at an oblique wrapping angle to provide a more directed focal spot size at a given depth inside of, for example, a patient's body. In certain configurations, the electrically conductive coil may be adjustable with respect to the magnetic core, such that the wrapping angle of the electrically conductive coil may be modified to, in turn, adjust the focal spot size of the induced electric field generated by the system as may desired to concentrate the field at a particularly desired location.Type: GrantFiled: January 10, 2020Date of Patent: December 26, 2023Assignees: University of Maryland, Baltimore, University of Maryland, Baltimore CountyInventors: L. Elliot Hong, Fow-Sen Choa, Qinglei Meng
-
Patent number: 11850066Abstract: A system and method for measuring and monitoring blood pressure is provided. The system includes a wearable device and a tonometry device coupled to the wearable device. The Tonometry device is configured to compress a superficial temporal artery (STA] of a user. A sensor pad is attached to the wearable device adjacent the tonometry device. A blood pressure sensor is integrated within the sensor pad for continuous, unobtrusive blood pressure monitoring.Type: GrantFiled: October 31, 2014Date of Patent: December 26, 2023Assignee: The General Hospital CorporationInventors: Quan Zhang, Yuanting Zhang
-
Patent number: 11850367Abstract: A treatment device configured noninvasively to treat neurological conditions and/or neuropsychiatric conditions, designed to modulate autonomic nervous system through biofeedback configured to change brain network. The treatment device comprising: physiological sensor, storage piling psychological data and operating controller to effectively provide at least one of biofeedback and tactile stimulation to the individual to curtail neurological and/or neuropsychiatric events.Type: GrantFiled: November 28, 2017Date of Patent: December 26, 2023Inventor: Yoko Nagai
-
Patent number: 11850060Abstract: Systems and methods for managing sleep quality of a patient, comprising: collecting physiological signal data of the patient using a data acquisition unit electrically coupled to at least one sensor affixed to the patient that generates the physiologic signal data; using one or more hardware processors executing instructions stored in a storage device: filtering the physiological signal data into a plurality of frequency bands corresponding to a plurality of power spectra waveforms; and characterizing an etiology of sleep quality of the patient based on a comparison of at least a first power spectra waveform of the plurality of power spectra waveforms against at least a second power spectra waveform of the plurality of power spectra waveforms, wherein the sleep quality of the patient is managed based on the characterized etiology of sleep.Type: GrantFiled: March 19, 2021Date of Patent: December 26, 2023Assignee: ADVANCED BRAIN MONITORING, INC.Inventors: Daniel J. Levendowski, Bratislav Veljkovic, Amy Matthews, Vladislav Velimirovic, Elise Ramos Angel, Christine Berka, Gene Davis, Aleksandar Zoranovic, Milenko Cvetinovic, Philip R. Westbrook
-
Patent number: 11839773Abstract: An item of footwear for magnetotherapy comprises a lower sole in which there is defined a tread surface, an intermediate container which can be received in an opening which is defined in the lower sole, a magnetic field generator, a control unit, a battery, an inner sole which is or can be placed over the intermediate container and a vamp structure which is connected to the lower sole. The intermediate container is produced from material having greater rigidity with respect to the lower sole and comprises respective recesses which are intended to receive the magnetic field generator, the control unit and the battery, respectively.Type: GrantFiled: January 30, 2018Date of Patent: December 12, 2023Assignee: ALBERTO DEL BIONDI S.P.A.Inventors: Alberto Del Biondi, Alessio Ivan Rizzi
-
Patent number: 11833021Abstract: Described are methods of treating urinary incontinence using a urinary sling and a tissue path that passes through the obturator foramen, along with related surgical implants, devices, systems and kits.Type: GrantFiled: July 13, 2021Date of Patent: December 5, 2023Assignee: Boston Scientific Scimed, Inc.Inventors: Christian Gozzi, Peter Rehder
-
Patent number: 11832937Abstract: An injector for transcutaneously introducing a sensor into a patient, including a cannula, a sensor arranged in the cannula, a base element, a sliding element arranged displaceably on the base element in an injection direction, for transcutaneously introducing the cannula having the sensor into the patient in an injection operation. The cannula has a slot in a longitudinal direction of the cannula. The injector has a holding element arranged displaceably on the base element that, in an ejection operation, prevents the sensor from being pulled out as the cannula is withdrawn, by engaging in a distal end region of the sensor through the slot into the cannula. The holding element and/or base element have at least one fixing arrangement to automatically lock the holding element on the base element when the cannula is introduced transcutaneously into the patient. A method for transcutaneously introducing a sensor into a patient is also provided.Type: GrantFiled: January 22, 2019Date of Patent: December 5, 2023Assignee: EYESENSE GMBHInventors: Achim Muller, Tom Meissner-Braun, Matthias Pischan
-
Patent number: 11832970Abstract: Systems and methods for monitoring patients for risk of worsening heart failure (WHF) are discussed. A patient management system includes a sensor circuit to receive respiration measurements, and an input device to receive patient dyspnea descriptor indicating dyspnea symptom severity. The system includes a risk analyzer circuit to trend the respiration measurement over time, and to generate a WHF risk indicator using both the trended respiration measurement and the received dyspnea descriptor. A control circuit controls the receiver circuit to receive the dyspnea descriptor in response to the trended respiration measurement satisfying a specific condition. The system can present the WHF risk indicator to a user or a process, or deliver or adjust a HF therapy based on the WHF risk indicator.Type: GrantFiled: July 26, 2018Date of Patent: December 5, 2023Assignee: Cardiac Pacemakers, Inc.Inventors: Qi An, Pramodsingh Hirasingh Thakur, Yi Zhang, Viktoria A Averina
-
Patent number: 11806134Abstract: In some embodiments, a sensor assembly for a continuous glucose monitoring system is provided that includes (1) a sensor carrier having a sensor unit receiving area and an electronics receiving area, the electronics receiving area including a substrate; (2) a sensor unit having a sterilized region, the sterilized region including at least a portion of a sensor and an introducer; and (3) electronics for the continuous glucose monitoring system. The sensor unit is positioned within the sensor unit receiving area of the sensor carrier and the electronics are positioned on the substrate within the electronics receiving area of the sensor carrier so as to form a sensor assembly having the sensor electrically connected to the substrate of the electronics receiving area while maintaining sterilization of the sterilized region of the sensor unit. Numerous other aspects are provided.Type: GrantFiled: May 8, 2018Date of Patent: November 7, 2023Assignee: Ascensia Diabetes Care Holdings AGInventors: Eugene Prais, Jennifer L. Gass, Nihir Patel, Nikhil M. Shah
-
Patent number: 11801344Abstract: Disclosed are a system, methods and computer-readable medium products that provide bolus dosage calculations by a control algorithm-based drug delivery system that provides automatic delivery of a drug, such as insulin or the like, based on sensor input. Blood glucose measurement values may be received at regular time intervals from a sensor. Using the blood glucose measurements, the control algorithm may perform various calculations and determinations to provide an appropriate bolus dosage. The appropriate bolus dosage may be used to respond to a trend in a trajectory of blood glucose measurements. In addition, a bolus dosage may also be determined by the disclosed device, system, method and/or computer-readable medium product in response to an indication that a user consumed a meal.Type: GrantFiled: September 13, 2019Date of Patent: October 31, 2023Assignee: INSULET CORPORATIONInventors: Steven Cardinali, Joon Bok Lee, Jason O'Connor, Yibin Zheng
-
Patent number: 11794029Abstract: Combined methods for treating a patient using time-varying magnetic field are described. The treatment methods combine various approaches for aesthetic treatment. The methods are focused on enhancing a visual appearance of the patient.Type: GrantFiled: November 14, 2022Date of Patent: October 24, 2023Assignee: BTL Medical Solutions A.S.Inventors: Tomas Schwarz, Ondra Prouza
-
Patent number: 11786746Abstract: Exemplary magnetic hyperthermia treatment systems and methods involve placing a conducting particle having a diameter of 500 microns within a tumor of a patient; and heating the conducting particle with an oscillating magnetic field. In some cases, the particle has a diameter or dimension with a value within a range of about 20 microns to about 1000 microns. In some cases, particle has a diameter or dimension with a value that is greater than 1000 microns.Type: GrantFiled: July 19, 2021Date of Patent: October 17, 2023Inventor: Brian Faircloth
-
Patent number: 11779256Abstract: Provided is a method for mapping a neural area involved in speech processing, including applying a plurality of recording electrodes to a surface of a cortex of a human subject, presenting a plurality of auditory stimuli to the subject wherein some of the plurality of stimuli are speech sounds and others of the plurality of auditory stimuli are non-speech sounds, recording brain activity during the presenting of the plurality of auditory stimuli, and identifying one or more brain areas wherein activity changes more after presentation of speech sounds than it does after presentation of non-speech sounds, wherein the human subject does not speak during the presenting and the recording. Also provided is a method for mapping a neural area involved in speech production wherein the human subject does not speak during presenting speech stimuli and recording neural activity.Type: GrantFiled: July 1, 2021Date of Patent: October 10, 2023Assignees: HEALTH RESEARCH, INC., ALBANY MEDICAL COLLEGEInventors: Gerwin Schalk, Anthony L. Ritaccio, Adriana De Pesters, AmiLyn Taplin
-
Patent number: 11779244Abstract: A device for attaching a localization marker to the lower jaw of an individual. The marker includes an inner face provided with two attachment lugs including an intra-oral portion having a general U-shape adapted for coming into contact with the outer face of the teeth of the lower jaw, an extra-oral portion including an attachment element for the marker, a connecting portion connecting the intra-oral portion and the extra-oral portion. The attachment element includes two recesses each adapted for receiving a respective lug of the marker, the recesses being separated by a tab adapted for being elastically deformed when one of the lugs is engaged in a respective recess so as to exert a pressure force on the lug.Type: GrantFiled: March 5, 2018Date of Patent: October 10, 2023Assignee: MODJAWInventor: Maxime Jaisson
-
Patent number: 11752254Abstract: A nuclear medicine infusion system (10) may be used to generate and infuse radioactive liquid into a patient undergoing a diagnostic imaging procedure. In some examples, the infusion system includes a frame (30) that carries a radioisotope generator (52) that generates radioactive eluate via elution. The frame may also carry a beta detector (58) and a gamma detector (60). The beta detector can be positioned to measure beta emissions emitted from the radioactive eluate supplied by the generator. The gamma detector can be positioned to measure gamma emissions emitted from a portion of the radioactive eluate to evaluate a safety of the radioactive eluate delivered by the infusion system.Type: GrantFiled: September 20, 2017Date of Patent: September 12, 2023Assignee: Bracco Diagnostics Inc.Inventors: Clif Moyers, Adrian Nunn, Andrew Schimmoeller, Brian Cherundolo